Estrogen enhances ER-α-positive breast cancer cell viability and motility through activating ΔNp63, an N-terminally truncated isoform of the p63 transcription factor, through the ERα-ΔNp63 integrin β4 signaling pathway, to induce AKT phosphorylation [21]. Here, ESR1 is linked to breast carcinoma.